Q301--NEW – STX Specialized Molecular Residual Disease Testing
Special Notice from Department of Veterans Affairs.
Data as of Oct 24, 2026. Sources: SAM.gov and Grants.gov. Snapshot govcon-directory-20261024T104923Z-2151694.
This product uses the Grants.gov API but is not endorsed or certified by the U.S. Department of Health and Human Services. Counts and totals are computed by DSE from public SAM.gov and Grants.gov notices. Text from Grants.gov may be shortened or have contact details removed. The original notice on Grants.gov is the authoritative version.
Closing in 6 days
Notice details
- Sub-tier agency
- VETERANS AFFAIRS, DEPARTMENT OF
- Notice type
- Special Notice
- Solicitation number
- 36C25727Q0058
- Product/service code
- Q301
- Posted
- Oct 23, 2026
- Response deadline
- Oct 30, 2026
- Source
- SAM.gov
Description
Special Notice Special Notice Page 3 of 3 Special Notice *= Required Field Special Notice Page 1 of 3 1. NOTICE OF INTENT DESCRIPTION The Department of Veterans Affairs, Network Contracting Office (NCO) 17, located at 5441 Babcock Road, Suite 302, San Antonio, TX 78229, intends to award an Indefinite Delivery Indefinite Quantity (IDIQ) Firm Fixed Price contract with five ordering periods on a sole-source basis to: Natera, Inc. 13011 McCallen Pass Austin, TX 78752 This requirement is for proprietary molecular genetic reference testing services used in the evaluation and monitoring of transplant patients and cancer residual disease. 2. SUPPLIES/SERVICES Item 0001 Description: Signatera Only, CPT Codes 81479, 81455 Estimated Quantity: 35 Unit: Each Item 0002 Description: Prospera, CPT Code 81479 Estimated Quantity: 25 Unit: Each Natera is the sole provider of these proprietary medical laboratory tests, including: Prospera molecular expression transplant assessment test Signatera Residual Disease Test (MRD) (non liquid biopsy tumor typing) No other vendor possesses the proprietary methodologies, assays, or intellectual property required to perform these tests. 3. SOLE SOURCE JUSTIFICATION Testing required by the VA is proprietary to Natera, Inc. No authorized distributors, third party laboratories, or alternative clinical sources exist for the Prospera and Signatera MRD tests. These assays cannot be substituted or performed by any other laboratory. Only Natera maintains the
Summarized from the official notice. The description is shortened; read the full text on the official notice.
Official notice
Requirements and amendments are controlled by the official notice.
DSE verdict
The DSE fit verdict for this notice is available to DSE GovCon subscribers. It is not published on this page.
See DSE GovCon plans →Similar open notices
- Q301--FY27 (BASE+4) STAT Laboratory Testing - Syracuse (VA-27-00010334)Closing in 6 days
- NWI Offsite Pathology ServicesClosing in 17 days
- EMERGENT REFERENCE LAB TESTINGClosing in 26 days
- Q301--Reference Laboratory TestingClosing in 37 days
- RFP-797-FSS-04-0001-R3: 621II Medical Laboratory Testing & Analysis ServicesClosing in 37 days
Get free alerts
Email alerts for notices like this one are free on DSE GovCon Intelligence.
Set up free alerts →Frequently asked questions
When is the response deadline?
The published deadline is Oct 30, 2026. That is 6 days after the data date.
What NAICS code applies?
NAICS 621511, Medical Laboratories.
Which agency issued this notice?
Department of Veterans Affairs.
Where is the official notice?
The link under Official notice opens the source listing.